Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7685
Reference
Name
Revised drug alert class 1 – Action now including out of hours – Clinigen Heathcare Ltd – Mexiletine Hydrochloride 50mg, 100mg and 200mg hard capsules – National Patient Safety Alert 2022 007
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
MEDICAL
PHARMACY
DRUG ALERT
NATIONAL PATIENT SAFETY ALERT
MEDICATIONS
Description
Please see attached revised drug alert to reflect a correction by Clinigen Healthcare Ltd, an update to correct the expiry date to 02/2024 and National Patient Safety alert about the potential for over or under dosing of three batches of mexiletine hydrochloride for onward transmission.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2022-08-04 00:00:00
Click to go back to homepage